Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2020

01-06-2020 | Affective Disorder | Review article

Chromium Supplementation; Negotiation with Diabetes Mellitus, Hyperlipidemia and Depression

Authors: Amir Khodavirdipour, Fatemeh Haddadi, Shiva Keshavarzi

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2020

Login to get access

Abstract

Chromium (Cr) is an essential trace element which found naturally in a daily diet and available in the form of supplementary tablets to boost disorders like diabetes mellitus (DM) and functions like lipid metabolism and beneficial on depression too. Diabetes is one of the most prevalent endocrine diseases or in other words, the most severe metabolic syndrome (MS), which associated with high production of free-radicals which is out of bodies detoxifying machine capacity or high oxidative stress (HOS), vasculitis and elevated lipid profile. many research papers and clinical trials published about the significance of chromium on biological activities, pre and post clinical. For this review research articles, clinical trials, from 1st Jan’10 to 31st Dec’18 and refer literature for the biochemical, pharmacological and biological activity of Chromium. Primarily articles gathered from the above search engines. Then precisely according to our aim and goal and regarding designed objectives dismisses similar articles and finally came to 84 articles for the above said period. This review trying to cover the entire picture from what chromium is to the recent updates on their greater role in increasing insulin sensitivity of cells and enhancing lipid metabolism and even recent findings suggest its positive effects including prevention and ameliorating properties on depression. The biological activities, pharmacological features, clinical implications including efficacy and role of chromium compounds on the glycaemic index will be discussed. The outcome of this review is to bring the pros and cons of chromium supplementation along with is safety and toxicity concern beside molecular pathways, biochemistry and clinical trials, all in one comprehensive review.
Literature
1.
go back to reference Wilbur S, Abadin H, Fay M, Yu D, and Tencza B, Ingerman L, Klotzbach J, and James S. Textbook: toxicological profile for chromium. Division of Toxicology, Agency for Toxic Substances and Disease Registry, 1600 Clifton Road, Mailstop E-29, Atlanta, Georgia 30333; 2000. Wilbur S, Abadin H, Fay M, Yu D, and Tencza B, Ingerman L, Klotzbach J, and James S. Textbook: toxicological profile for chromium. Division of Toxicology, Agency for Toxic Substances and Disease Registry, 1600 Clifton Road, Mailstop E-29, Atlanta, Georgia 30333; 2000.
3.
4.
go back to reference Anderson RA. Chromium in the prevention and control of diabetes. Diabetes Metab. 2000;26(1):22–8.PubMed Anderson RA. Chromium in the prevention and control of diabetes. Diabetes Metab. 2000;26(1):22–8.PubMed
5.
go back to reference Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care. 2004;27(11):2741–51.PubMedCrossRef Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care. 2004;27(11):2741–51.PubMedCrossRef
6.
go back to reference Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States. JAMA. 2006;295(13):1549–55.PubMedCrossRef Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States. JAMA. 2006;295(13):1549–55.PubMedCrossRef
8.
go back to reference Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–32.PubMedCrossRef Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–32.PubMedCrossRef
9.
go back to reference Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.PubMedCrossRef Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.PubMedCrossRef
10.
go back to reference Popkin BM. Recent dynamics suggest selected countries catching up to US obesity. Am J Clin Nutr. 2010;91:284–8.CrossRef Popkin BM. Recent dynamics suggest selected countries catching up to US obesity. Am J Clin Nutr. 2010;91:284–8.CrossRef
11.
go back to reference Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–41.PubMedCrossRef Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–41.PubMedCrossRef
12.
go back to reference Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm EB. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol. 2004;159:1150–9.PubMedCrossRef Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm EB. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol. 2004;159:1150–9.PubMedCrossRef
13.
go back to reference Yeghiazaryan K, Schild H, Golubnitschaja O. Chromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics. Infect Disord Drug Targets. 2012;12(5):332–9.PubMedPubMedCentralCrossRef Yeghiazaryan K, Schild H, Golubnitschaja O. Chromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics. Infect Disord Drug Targets. 2012;12(5):332–9.PubMedPubMedCentralCrossRef
14.
go back to reference Glaser E, Halpern G. Uber Die Aktivierung des Insulins Durch Hefeprebasft. Biochem Z. 1929;207:377–83 (Article in German). Glaser E, Halpern G. Uber Die Aktivierung des Insulins Durch Hefeprebasft. Biochem Z. 1929;207:377–83 (Article in German).
15.
go back to reference Schwarz K, Mertz W. A glucose tolerance factor and its differentiation from factor 3. Arch Biochem Biophys. 1957;72(2):515–8.PubMedCrossRef Schwarz K, Mertz W. A glucose tolerance factor and its differentiation from factor 3. Arch Biochem Biophys. 1957;72(2):515–8.PubMedCrossRef
16.
go back to reference Colapinto ND, Bedard P, Goldman BS. Bloodstream infection associated with prolonged intravenous therapy. Canadian journal of surgery. Journal canadien de chirurgie. 1972;15(1):27–9.PubMed Colapinto ND, Bedard P, Goldman BS. Bloodstream infection associated with prolonged intravenous therapy. Canadian journal of surgery. Journal canadien de chirurgie. 1972;15(1):27–9.PubMed
17.
go back to reference Chen YL, Lin JD, Hsia TL, Mao FC, Hsu CH, Pei D. The effect of chromium on inflammatory markers, 1st and 2nd phase insulin secretionin type 2 diabetes. Eur J Nutr. 2014;53(1):127–33.PubMedCrossRef Chen YL, Lin JD, Hsia TL, Mao FC, Hsu CH, Pei D. The effect of chromium on inflammatory markers, 1st and 2nd phase insulin secretionin type 2 diabetes. Eur J Nutr. 2014;53(1):127–33.PubMedCrossRef
18.
go back to reference Wilson BE, Gondy A. Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Res Clin Pract. 1995;28(3):179–84.PubMedCrossRef Wilson BE, Gondy A. Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Res Clin Pract. 1995;28(3):179–84.PubMedCrossRef
19.
go back to reference San Mauro Martín I, Ruiz León AM, Garicano Vilar E, Camina Martín MA, de Mateo-Silleras B, de Paz Redondo del Río M and et al. Chromium supplementation in patients with type 2 diabetes and high risk of type 2 diabetes: a meta-analysis of randomized controlled trials. Nutr Hosp. 2016; 33(1). San Mauro Martín I, Ruiz León AM, Garicano Vilar E, Camina Martín MA, de Mateo-Silleras B, de Paz Redondo del Río M and et al. Chromium supplementation in patients with type 2 diabetes and high risk of type 2 diabetes: a meta-analysis of randomized controlled trials. Nutr Hosp. 2016; 33(1).
20.
go back to reference Aziza AK and El Mugdad AA Preparation, characterization and biological activity Chromium Phthalocyanine chloride complex. 2012 Dept. of chem. Sudan university of science and technology (SUST). Aziza AK and El Mugdad AA Preparation, characterization and biological activity Chromium Phthalocyanine chloride complex. 2012 Dept. of chem. Sudan university of science and technology (SUST).
23.
go back to reference Bury TF, van Vroonhoven TJ, Stuifbergen WN. The role of surgical intervention in the treatment of patients with Crohn's disease. Ned Tijdschr Geneeskd. 1988;132(53):2414.PubMed Bury TF, van Vroonhoven TJ, Stuifbergen WN. The role of surgical intervention in the treatment of patients with Crohn's disease. Ned Tijdschr Geneeskd. 1988;132(53):2414.PubMed
24.
go back to reference Rains JL, Jain SK. Oxidative stress, insulin signalling and diabetes. Free Radic Biol Med. 2011;50:567–75.CrossRefPubMed Rains JL, Jain SK. Oxidative stress, insulin signalling and diabetes. Free Radic Biol Med. 2011;50:567–75.CrossRefPubMed
25.
go back to reference Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 2003;546:113–20.PubMedCrossRef Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 2003;546:113–20.PubMedCrossRef
26.
go back to reference Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, Walter M, et al. AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans. 2003;31:162–8.PubMedCrossRef Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, Walter M, et al. AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans. 2003;31:162–8.PubMedCrossRef
27.
go back to reference Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem. 1995;270:17513–20.PubMedCrossRef Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem. 1995;270:17513–20.PubMedCrossRef
28.
go back to reference Winder WW, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Phys. 1996;270:E299–304. Winder WW, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Phys. 1996;270:E299–304.
29.
30.
go back to reference Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care. 2007;30(8):2154–63.PubMedCrossRef Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care. 2007;30(8):2154–63.PubMedCrossRef
31.
go back to reference Yechoor VK, Patti M-E, Ueki K, Laustden PG, Saccone R, Rauniyar R, et al. Distinct pathways of insulin-regulated vs diabetes-regulated gene expression: an in vivo analysis in MIRKO mice. Proc Natl Acad Sci U S A. 2004;101(47):16525–30.PubMedPubMedCentralCrossRef Yechoor VK, Patti M-E, Ueki K, Laustden PG, Saccone R, Rauniyar R, et al. Distinct pathways of insulin-regulated vs diabetes-regulated gene expression: an in vivo analysis in MIRKO mice. Proc Natl Acad Sci U S A. 2004;101(47):16525–30.PubMedPubMedCentralCrossRef
32.
go back to reference Sun Y, Ramirez J, Woski SA, Vincent JB. The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr. JBIC J Biol Inorg Chem. 2000;5(1):129–36.PubMedCrossRef Sun Y, Ramirez J, Woski SA, Vincent JB. The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr. JBIC J Biol Inorg Chem. 2000;5(1):129–36.PubMedCrossRef
33.
go back to reference Hepburn DD, Vincent JB. Tissue and subcellular distribution of chromium picolinate with time after entering the bloodstream. J Inorg Biochem. 2003;94:86–93.PubMedCrossRef Hepburn DD, Vincent JB. Tissue and subcellular distribution of chromium picolinate with time after entering the bloodstream. J Inorg Biochem. 2003;94:86–93.PubMedCrossRef
34.
go back to reference Wasser WG, Feldman NS, D’Agati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate (Letter). Ann Intern Med. 1997;126:410.PubMedCrossRef Wasser WG, Feldman NS, D’Agati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate (Letter). Ann Intern Med. 1997;126:410.PubMedCrossRef
35.
go back to reference Institute of Medicine (IOM). Chromium picolinate: prototype monograph. In Dietary Supplements: A Framework for Evaluating Safety. Washington, DC, Institute of Medicine, 2004; p. B1-B80. Institute of Medicine (IOM). Chromium picolinate: prototype monograph. In Dietary Supplements: A Framework for Evaluating Safety. Washington, DC, Institute of Medicine, 2004; p. B1-B80.
36.
go back to reference Berner TO, Murphy MM, Slesinski R. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food Chem Toxicol. 2004;42:1029–42.PubMedCrossRef Berner TO, Murphy MM, Slesinski R. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food Chem Toxicol. 2004;42:1029–42.PubMedCrossRef
37.
go back to reference Jeejeebhoy KN. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev. 1999;57:329–35.PubMedCrossRef Jeejeebhoy KN. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev. 1999;57:329–35.PubMedCrossRef
38.
go back to reference Brownley KA, Boettiger CA, Young L, Cefalu WT. Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating. Med Hypotheses. 2015;85(1):45–8.PubMedPubMedCentralCrossRef Brownley KA, Boettiger CA, Young L, Cefalu WT. Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating. Med Hypotheses. 2015;85(1):45–8.PubMedPubMedCentralCrossRef
39.
go back to reference Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977;30(4):531–8.PubMedCrossRef Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977;30(4):531–8.PubMedCrossRef
40.
go back to reference Prasad A. Role of chromium compounds in diabetes. Indian J Pharm Pharmacol. 2016;3(1):17–23.CrossRef Prasad A. Role of chromium compounds in diabetes. Indian J Pharm Pharmacol. 2016;3(1):17–23.CrossRef
41.
go back to reference Gröber U, Kisters K, Schmidt J. Micronutrients in diabetology: complementary medicine update 2014. Med Monatsschr Pharm. 2014;37(8):284–92.PubMed Gröber U, Kisters K, Schmidt J. Micronutrients in diabetology: complementary medicine update 2014. Med Monatsschr Pharm. 2014;37(8):284–92.PubMed
42.
go back to reference Jacobs E, Hoyer A, Brinks R, Icks A, Kuß O, Rathmann W. Healthcare costs of Type 2 diabetes in Germany. Diabet Med. 2017;34(6):855–61.PubMedCrossRef Jacobs E, Hoyer A, Brinks R, Icks A, Kuß O, Rathmann W. Healthcare costs of Type 2 diabetes in Germany. Diabet Med. 2017;34(6):855–61.PubMedCrossRef
43.
go back to reference Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther. 2014;39(3):292–306.PubMedCrossRef Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther. 2014;39(3):292–306.PubMedCrossRef
44.
go back to reference Rotter I, Kosik-Bogocka D, Dolegowska B, Safranow K, Lubkowska A, Laszczynska M. Relationship between the concentration of heavy metals and bio elements in aging men with metabolic syndrome. Int J Environ Res Public Health. 2015;12(4):3944–61.PubMedPubMedCentralCrossRef Rotter I, Kosik-Bogocka D, Dolegowska B, Safranow K, Lubkowska A, Laszczynska M. Relationship between the concentration of heavy metals and bio elements in aging men with metabolic syndrome. Int J Environ Res Public Health. 2015;12(4):3944–61.PubMedPubMedCentralCrossRef
45.
go back to reference Sharma S, Agarwal RP, Choudhary M, Jain S, Goyal S, Agarwal V. Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes. J Trace Elem Med Biol. 2011;25(3):149–53.PubMedCrossRef Sharma S, Agarwal RP, Choudhary M, Jain S, Goyal S, Agarwal V. Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes. J Trace Elem Med Biol. 2011;25(3):149–53.PubMedCrossRef
46.
go back to reference Li Y, Li S, Meng X, Gan R-Y, Zhang J-J, Li H-B. Dietary Natural Products for Prevention and Treatment of Breast Cancer. Nutrients. 2017;9:728.PubMedCentralCrossRef Li Y, Li S, Meng X, Gan R-Y, Zhang J-J, Li H-B. Dietary Natural Products for Prevention and Treatment of Breast Cancer. Nutrients. 2017;9:728.PubMedCentralCrossRef
47.
go back to reference Lang UE, Beglinger C, Schweinfurth N, Walter M, Borgwardt S. Nutritional aspects of depression. Cell Physiol Biochem. 2015;37(3):1029.PubMedCrossRef Lang UE, Beglinger C, Schweinfurth N, Walter M, Borgwardt S. Nutritional aspects of depression. Cell Physiol Biochem. 2015;37(3):1029.PubMedCrossRef
48.
go back to reference Anderson RA, Polansky MM, Bryden NA, Bhathena SJ, Canary JJ. Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metab Clin Exp. 1987;36(4):351–5.PubMedCrossRef Anderson RA, Polansky MM, Bryden NA, Bhathena SJ, Canary JJ. Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metab Clin Exp. 1987;36(4):351–5.PubMedCrossRef
49.
go back to reference Sylvia LG, Peters AT, Deckersbach T, Nierenberg AA. Nutrient-based therapies for bipolar disorder: a systematic review. Psychother Psychosom. 2013;82(1):10–9.PubMedCrossRef Sylvia LG, Peters AT, Deckersbach T, Nierenberg AA. Nutrient-based therapies for bipolar disorder: a systematic review. Psychother Psychosom. 2013;82(1):10–9.PubMedCrossRef
50.
go back to reference Amann BL, Mergl R, Vieta E, Born C, Hermisson I, Seemueller F, et al. A 2-year, open-label pilot study of adjunctive chromium in patients with treatmentresistant rapid-cycling bipolar disorder. J Clin Psychopharmacol. 2007;2(7):104–6.CrossRef Amann BL, Mergl R, Vieta E, Born C, Hermisson I, Seemueller F, et al. A 2-year, open-label pilot study of adjunctive chromium in patients with treatmentresistant rapid-cycling bipolar disorder. J Clin Psychopharmacol. 2007;2(7):104–6.CrossRef
51.
go back to reference Attenburrow MJ, Williams C, Odonliatis J, Powell J, Van de Ouderaa F, Williams M, et al. The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5HT function. Psychol Med. 2003;33(8):1381–6.PubMedCrossRef Attenburrow MJ, Williams C, Odonliatis J, Powell J, Van de Ouderaa F, Williams M, et al. The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5HT function. Psychol Med. 2003;33(8):1381–6.PubMedCrossRef
52.
go back to reference Młyniec K, Davies CL, de Agueero Sanchez IG, Pytka K, Budziszewska B, Nowak G. Essential elements in depression and anxiety. Part I. Pharmacol Rep. 2014;66(4):534–44.PubMedCrossRef Młyniec K, Davies CL, de Agueero Sanchez IG, Pytka K, Budziszewska B, Nowak G. Essential elements in depression and anxiety. Part I. Pharmacol Rep. 2014;66(4):534–44.PubMedCrossRef
53.
go back to reference Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem. 2013;31:761–77.PubMedCrossRef Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem. 2013;31:761–77.PubMedCrossRef
54.
go back to reference Whitfield P, Parry-Strong A, Walsh E, Weatherall M, Krebs JD. The effect of a cinnamon-, chromium-and magnesium-formulated honey on glycaemic control, weight loss and lipid parameters in type 2 diabetes: an open-label cross-over randomised controlled trial. Eur J Nutr. 2016;55(3):1123–31.PubMedCrossRef Whitfield P, Parry-Strong A, Walsh E, Weatherall M, Krebs JD. The effect of a cinnamon-, chromium-and magnesium-formulated honey on glycaemic control, weight loss and lipid parameters in type 2 diabetes: an open-label cross-over randomised controlled trial. Eur J Nutr. 2016;55(3):1123–31.PubMedCrossRef
56.
go back to reference Azimi P, Ghiasvand R, Feizi A, Hosseinzadeh J, Bahreynian M, Hariri M, et al. Effect of cinnamon, cardamom, saffron and ginger consumption on blood pressure and a marker of endothelial function in patients with type 2 diabetes mellitus: A randomized controlled clinical trial. Blood Press. 2016;25(3):133–40.PubMedCrossRef Azimi P, Ghiasvand R, Feizi A, Hosseinzadeh J, Bahreynian M, Hariri M, et al. Effect of cinnamon, cardamom, saffron and ginger consumption on blood pressure and a marker of endothelial function in patients with type 2 diabetes mellitus: A randomized controlled clinical trial. Blood Press. 2016;25(3):133–40.PubMedCrossRef
57.
go back to reference Mirfeizi M, Mehdizadeh Tourzani Z, Mirfeizi SZ, Asghari Jafarabadi M, Rezvani HR, Afzali M. Controlling type 2 diabetes mellitus with herbal medicines: A triple-blind randomized clinical trial of efficacy and safety. J Diabetes. 2016;8(5):647–56.PubMedCrossRef Mirfeizi M, Mehdizadeh Tourzani Z, Mirfeizi SZ, Asghari Jafarabadi M, Rezvani HR, Afzali M. Controlling type 2 diabetes mellitus with herbal medicines: A triple-blind randomized clinical trial of efficacy and safety. J Diabetes. 2016;8(5):647–56.PubMedCrossRef
58.
go back to reference Liu Y, Cotillard A, Vatier C, Bastard JP, Fellahi S, Stévant M, et al. A dietary supplement containing cinnamon, chromium and carnosine decreases fasting plasma glucose and increases lean mass in overweight or obese pre-diabetic subjects: a randomized, placebo-controlled trial. PLoS One. 2015;10(9):e0138646.PubMedPubMedCentralCrossRef Liu Y, Cotillard A, Vatier C, Bastard JP, Fellahi S, Stévant M, et al. A dietary supplement containing cinnamon, chromium and carnosine decreases fasting plasma glucose and increases lean mass in overweight or obese pre-diabetic subjects: a randomized, placebo-controlled trial. PLoS One. 2015;10(9):e0138646.PubMedPubMedCentralCrossRef
59.
go back to reference McIver DJ, Grizales AM, Brownstein JS, Goldfine AB. Risk of Type 2 Diabetes Is Lower in US Adults Taking Chromium-Containing Supplements. J Nutr. 2015;145(12):2675–82.PubMedPubMedCentralCrossRef McIver DJ, Grizales AM, Brownstein JS, Goldfine AB. Risk of Type 2 Diabetes Is Lower in US Adults Taking Chromium-Containing Supplements. J Nutr. 2015;145(12):2675–82.PubMedPubMedCentralCrossRef
60.
go back to reference Peruzzu A, Solinas G, Asara Y, Forte G, Bocca B, Tolu F, et al. Association of trace elements with lipid profile and glycaemic control in patients with type 1 diabetes mellitus in northern Sardinia, Italy: An observational study. Chemosphere. 2015;132:101–7.PubMedCrossRef Peruzzu A, Solinas G, Asara Y, Forte G, Bocca B, Tolu F, et al. Association of trace elements with lipid profile and glycaemic control in patients with type 1 diabetes mellitus in northern Sardinia, Italy: An observational study. Chemosphere. 2015;132:101–7.PubMedCrossRef
61.
go back to reference Paiva AN, de Lima JG, de Medeiros AC, Figueiredo HA, de Andrade RL, Ururahy MA, et al. Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: a randomized clinical study. J Trace Elem Med Biol. 2015;32:66–72.PubMedCrossRef Paiva AN, de Lima JG, de Medeiros AC, Figueiredo HA, de Andrade RL, Ururahy MA, et al. Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: a randomized clinical study. J Trace Elem Med Biol. 2015;32:66–72.PubMedCrossRef
62.
go back to reference Hansen AF, Simić A, Åsvold BO, Romundstad PR, Midthjell K, Syversen T, et al. Trace elements in early phase type 2 diabetes mellitus-A population-based study. The HUNT study in Norway. J Trace Elem Med Biol. 2017;40:46–53.PubMedCrossRef Hansen AF, Simić A, Åsvold BO, Romundstad PR, Midthjell K, Syversen T, et al. Trace elements in early phase type 2 diabetes mellitus-A population-based study. The HUNT study in Norway. J Trace Elem Med Biol. 2017;40:46–53.PubMedCrossRef
63.
go back to reference Smic A, Hansen AF, Asvold BO, Romundstud PR, Midthjell K, Syversen T, et al. Trace elements status in patients with type 2 diabetes in Norway: the HUNT3 survey. J Trace Elem Med Biol. 2017;41:91–8.CrossRef Smic A, Hansen AF, Asvold BO, Romundstud PR, Midthjell K, Syversen T, et al. Trace elements status in patients with type 2 diabetes in Norway: the HUNT3 survey. J Trace Elem Med Biol. 2017;41:91–8.CrossRef
64.
go back to reference Harani H, Otmane A, Makrelouf M, Ouadahi N, Abdi A, Berrah A, et al. Preliminary evaluation of the antioxidant trace elements in an Algerian patient with type 2 diabetes: special role of manganese and chromium. Ann Boil Clin (Paris). 2012;70(6):669–77. Harani H, Otmane A, Makrelouf M, Ouadahi N, Abdi A, Berrah A, et al. Preliminary evaluation of the antioxidant trace elements in an Algerian patient with type 2 diabetes: special role of manganese and chromium. Ann Boil Clin (Paris). 2012;70(6):669–77.
65.
go back to reference Basaki M, Saeb M, Nazifi S, Shamsaei HA. Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus. Biol Trace Elem Res. 2012;148(2):161–4.PubMedCrossRef Basaki M, Saeb M, Nazifi S, Shamsaei HA. Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus. Biol Trace Elem Res. 2012;148(2):161–4.PubMedCrossRef
66.
go back to reference Adam AM, Sharshar T, Mohamed MA, Ibrahim OB, Refat MS. Study of chemical bonding, physical and biological effect of metformin drug as an organized medicine for diabetes patients with chromium (III) and vanadium (IV) ions. Spectrochim Acta A Mol Biomol Spectrosc. 2015;149:323–32.PubMedCrossRef Adam AM, Sharshar T, Mohamed MA, Ibrahim OB, Refat MS. Study of chemical bonding, physical and biological effect of metformin drug as an organized medicine for diabetes patients with chromium (III) and vanadium (IV) ions. Spectrochim Acta A Mol Biomol Spectrosc. 2015;149:323–32.PubMedCrossRef
67.
go back to reference Gröber U, Kister K, Schmidt J: Micronutrients in diabetology: complementary medicine. Med Monatsschr Pharm 2004 Aug. Lang: German. Gröber U, Kister K, Schmidt J: Micronutrients in diabetology: complementary medicine. Med Monatsschr Pharm 2004 Aug. Lang: German.
68.
go back to reference Vincent JB. Elucidating a biological role for chromium at a molecular level. Acc Chem Res. 2000;33(7):503–10.PubMedCrossRef Vincent JB. Elucidating a biological role for chromium at a molecular level. Acc Chem Res. 2000;33(7):503–10.PubMedCrossRef
69.
go back to reference Abraham AS, Brooks BA, Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metab Clin Exp. 1992;41(7):768–71.PubMedCrossRef Abraham AS, Brooks BA, Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metab Clin Exp. 1992;41(7):768–71.PubMedCrossRef
70.
go back to reference Bahijiri SM, Mira SA, Mufti AM, Ajabnoor MA. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med J. 2000;21(9):831–7.PubMed Bahijiri SM, Mira SA, Mufti AM, Ajabnoor MA. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med J. 2000;21(9):831–7.PubMed
71.
go back to reference Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care. 1994;17(12):1449–52.PubMedCrossRef Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care. 1994;17(12):1449–52.PubMedCrossRef
72.
go back to reference Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46(11):1786–91.PubMedCrossRef Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46(11):1786–91.PubMedCrossRef
73.
go back to reference Ghosh D, Bhattacharya B, Mukherjee B, Manna B, Sinha M, Chowdhury J, et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutr Biochem. 2002;13(11):690–7.PubMedCrossRef Ghosh D, Bhattacharya B, Mukherjee B, Manna B, Sinha M, Chowdhury J, et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutr Biochem. 2002;13(11):690–7.PubMedCrossRef
74.
go back to reference Chen SH, Sun YP, Chen XS. Effect of jiangtangkang on blood glucose, sensitivity of insulin and blood viscosity in non-insulin dependent diabetes mellitus. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997;17(11):666–8.PubMed Chen SH, Sun YP, Chen XS. Effect of jiangtangkang on blood glucose, sensitivity of insulin and blood viscosity in non-insulin dependent diabetes mellitus. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997;17(11):666–8.PubMed
75.
go back to reference Uusitupa MI, Kumpulainen JT, Voutilainen E, Hersio K, Sarlund H, Pyörälä KP, et al. Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr. 1983;38(3):404–10.PubMedCrossRef Uusitupa MI, Kumpulainen JT, Voutilainen E, Hersio K, Sarlund H, Pyörälä KP, et al. Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr. 1983;38(3):404–10.PubMedCrossRef
76.
go back to reference Rabinowitz MB, Gonick HC, Levin SR, Davidson MB. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care. 1983;6(4):319–27.PubMedCrossRef Rabinowitz MB, Gonick HC, Levin SR, Davidson MB. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care. 1983;6(4):319–27.PubMedCrossRef
77.
go back to reference Uusitupa MI, Mykkänen L, Siitonen O, Laakso M, Sarlund H, Kolehmainen P, et al. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br J Nutr. 1992;68(1):209–16.PubMedCrossRef Uusitupa MI, Mykkänen L, Siitonen O, Laakso M, Sarlund H, Kolehmainen P, et al. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br J Nutr. 1992;68(1):209–16.PubMedCrossRef
78.
go back to reference Offenbacher EG, Pi-Sunyer FX. Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes. 1980;29(11):919–25.PubMedCrossRef Offenbacher EG, Pi-Sunyer FX. Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes. 1980;29(11):919–25.PubMedCrossRef
79.
go back to reference Evans GW. The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosoc Med Res. 1989;11(2):163–80. Evans GW. The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosoc Med Res. 1989;11(2):163–80.
80.
go back to reference Roeback JR, Hla KM, Chambless LE, Fletcher RH. Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers: a randomized, controlled trial. Ann Intern Med. 1991;115(12):917–24.PubMedCrossRef Roeback JR, Hla KM, Chambless LE, Fletcher RH. Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers: a randomized, controlled trial. Ann Intern Med. 1991;115(12):917–24.PubMedCrossRef
81.
go back to reference Riales R, Albrink MJ. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr. 1981;34(12):2670–8.PubMedCrossRef Riales R, Albrink MJ. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr. 1981;34(12):2670–8.PubMedCrossRef
82.
go back to reference Press RI, Geller J, Evans GW. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med. 1990;152(1):41.PubMedPubMedCentral Press RI, Geller J, Evans GW. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med. 1990;152(1):41.PubMedPubMedCentral
83.
go back to reference Preuss HG, Wallerstedt D, Talpur N, Tutuncuoglu SO, Echard B, Myers A, et al. Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. J Med. 2000;31(5-6):227–46.PubMed Preuss HG, Wallerstedt D, Talpur N, Tutuncuoglu SO, Echard B, Myers A, et al. Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. J Med. 2000;31(5-6):227–46.PubMed
84.
go back to reference Volpe SL, Huang HW, Larpadisorn K, Lesser II. Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J Am Coll Nutr. 2001;20(4):293–306.PubMedCrossRef Volpe SL, Huang HW, Larpadisorn K, Lesser II. Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J Am Coll Nutr. 2001;20(4):293–306.PubMedCrossRef
85.
go back to reference Amato P, Morales AJ, Yen SS. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women. J Gerontol Ser A Biol Med Sci. 2000;55(5):M260–3.CrossRef Amato P, Morales AJ, Yen SS. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women. J Gerontol Ser A Biol Med Sci. 2000;55(5):M260–3.CrossRef
86.
go back to reference Cefalu WT, Bell-Farrow AD, Stegner J, Wang ZQ, King T, Morgan T, et al. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med. 1999;12(2):71–83.CrossRef Cefalu WT, Bell-Farrow AD, Stegner J, Wang ZQ, King T, Morgan T, et al. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med. 1999;12(2):71–83.CrossRef
Metadata
Title
Chromium Supplementation; Negotiation with Diabetes Mellitus, Hyperlipidemia and Depression
Authors
Amir Khodavirdipour
Fatemeh Haddadi
Shiva Keshavarzi
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00501-8

Other articles of this Issue 1/2020

Journal of Diabetes & Metabolic Disorders 1/2020 Go to the issue